Development of an adherence to Iron-Chelation Therapy measure through a qualitative study: patient and caregiver perspectives in transfusion-dependent anemias and myelodysplastic syndrome

被引：0
|
作者：
Lasch, Kathryn E. [1 ]
Horodniceanu, Erica G. [1 ]
Bal, Vasudha [2 ]
Cote, Isabelle [2 ]
Dorgan, Amy [2 ]
Malet, Isabelle [2 ]
机构：
[1] Pharmerit Int, Cambridge, MA USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
QUALITY OF LIFE RESEARCH | 2014年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
2013
引用
收藏
页码：105 / 105
页数：1
相关论文
共 29 条
  • [1] Iron chelation therapy in patients with transfusion-dependent myelodysplastic syndrome
    Mast, Alan E.
    Field, Joshua J.
    TRANSFUSION, 2012, 52 (10) : 2078 - 2080
  • [2] Iron chelation therapy in sickle-cell disease and other transfusion-dependent anemias
    Kwiatkowski, JL
    Cohen, AR
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (06) : 1355 - +
  • [3] Heterogeneity of myocardial iron distribution in response to chelation therapy in patients with transfusion-dependent anemias
    Hanneman, Kate
    Raju, Vikram M.
    Moshonov, Hadas
    Ward, Richard
    Wintersperger, Bernd J.
    Crean, Andrew M.
    Ross, Heather
    Nguyen, Elsie T.
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2013, 29 (07): : 1517 - 1526
  • [4] A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients
    Theppornpitak, Krisada
    Trakarnsanga, Bussaba
    Lauhasurayotin, Supanun
    Poparn, Hansamon
    Chiengthong, Kanhatai
    Sosothikul, Darintr
    Techavichit, Piti
    HEMOGLOBIN, 2021, 45 (03) : 171 - 174
  • [5] Heterogeneity of myocardial iron distribution in response to chelation therapy in patients with transfusion-dependent anemias
    Kate Hanneman
    Vikram M. Raju
    Hadas Moshonov
    Richard Ward
    Bernd J. Wintersperger
    Andrew M. Crean
    Heather Ross
    Elsie T. Nguyen
    The International Journal of Cardiovascular Imaging, 2013, 29 : 1517 - 1526
  • [6] IRON OVERLOAD AND IRON CHELATION THERAPY WITH DEFERASIROX IN TRANSFUSION-DEPENDENT PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Del Corso, L.
    Bacigalupo, A.
    Balleari, E.
    Bellodi, A.
    Calzamiglia, T.
    Da Col, A.
    D'elia, P.
    Dominietto, A.
    Favorini, S.
    Forni, G.
    Galimberti, S.
    Ghio, M.
    Ghio, R.
    Salvetti, C.
    Ubezio, G.
    Vignolo, L.
    Molinari, E.
    Ghiso, A.
    Drousseau, M.
    Simonetti, F.
    Goretti, R.
    Tassara, R.
    Racchi, O.
    Scudeletti, M.
    Arboscello, E.
    Gianluca, F.
    LEUKEMIA RESEARCH, 2015, 39 : S150 - S150
  • [7] IRON CHELATION THERAPY IN MYELODYSPLASTIC SYNDROMES AND IN OTHER TRANSFUSION-DEPENDENT CHRONIC ANEMIAS. RETROSPECTIVE STUDY OF 69 PATIENTS FROM A SINGLE INSTITUTION
    Finelli, C.
    Clissa, C.
    Barraco, M.
    De Maio, C.
    Stanzani, M.
    Parisi, S.
    Paolini, S.
    Bosi, C.
    Cavo, M.
    HAEMATOLOGICA, 2017, 102 : 770 - 771
  • [8] Iron overload-related heart failure in a patient with transfusion-dependent myelodysplastic syndrome reversed by intensive combined chelation therapy
    Pinto, Valeria
    Balocco, Manuela
    Ambaglio, Ilaria
    Derchi, Giorgio
    Malcovati, Luca
    Forni, Gian Luca
    CLINICAL CASE REPORTS, 2015, 3 (11): : 952 - 954
  • [9] Patient and Caregiver Perspectives of Factors Associated with Adherence to and Satisfaction with Iron Chelation Therapy
    Bal, Vasudha
    Cote, Isabelle
    Lasch, Kathryn
    Huang, Vicky
    BLOOD, 2014, 124 (21)
  • [10] IRON CHELATION THERAPY IN TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE STUDY OF 53 PATIENTS IN A SINGLE INSTITUTION
    Finelli, C.
    Clissa, C.
    Barraco, M.
    De Maio, C.
    Fogli, M.
    Stanzani, M.
    Parisi, S.
    Paolini, S.
    Bosi, C.
    Cavo, M.
    HAEMATOLOGICA, 2017, 102 : 57 - 57
123